CELL DAMAGE INDUCING THERAPEUTIC MEDICINAL PRODUCT FOR ANTICANCER THERAPY Russian patent published in 2021 - IPC A61K39/395 A61P35/00 C07K16/46 C07K16/28 

Abstract RU 2746754 C2

FIELD: biotechnology.

SUBSTANCE: proposed is an anti-cancer agent containing a bispecific antibody as an active ingredient. Stated bispecific antibody contains variable areas of the antibody connecting with glypican 3 and CD3 and contains identical light strands. Also proposed is a pharmaceutical composition containing a bispecific antibody as an active ingredient. Composition is intended for co-use with another anti-cancer medicinal product. Invention also relates to cytotoxicity induction, cellular proliferation inhibition and immune response activation agents containing such composition. Bispecific antibodies constitute new and highly safe molecules characterized by high processability, strong antitumor activity and very high pharmacokinetic properties.

EFFECT: invention may be used in treatment of various types of cancer.

17 cl, 47 dwg, 21 tbl, 15 ex

Similar patents RU2746754C2

Title Year Author Number
CYTOTOXICITY-INDUCING THERAPEUTIC AGENT 2015
  • Nezu Junichi
  • Narita Atsushi
  • Ishiguro Takahiro
  • Sakurai Mika
  • Shiraiwa Hirotake
  • Hironiwa Naoka
  • Igawa Tomoyuki
  • Kawai Yumiko
RU2812875C1
CYTOTOXICITY-INDUCING THERAPEUTIC AGENT 2015
  • Nedzu Dzyuniti
  • Narita Atsuki
  • Isiguro Takakhiro
  • Sakurai Mika
  • Siraiva Khirotake
  • Khironiva Naoka
  • Igava Tomoyuki
  • Kavai Yumiko
RU2743464C2
ANTIBODY TO GLYPICAN 3 2011
RU2611751C2
GLYPICAN-3 ANTIBODY 2005
  • Nakano Kijotaka
  • Josino Takesi
  • Nezu Dzun-Iti
  • Tsunoda Khirojuki
  • Igava Tomojuki
  • Konisi Khiroko
  • Tanaka Megumi
  • Zugo Izumi
  • Kavai Sigeto
  • Isiguro Takakhiro
  • Kinosita Jasuko
RU2427588C2
CANCER TREATMENT WITH CHIMERIC CD33 ANTIGEN RECEPTOR 2015
  • Brogdon Jennifer
  • Ebersbach Hilmar
  • Gill Saar
  • Glass David
  • Huber Thomas
  • Jascur Julia
  • Kenderian Saad
  • Mannick Joan
  • Milone Michael C.
  • Murphy Leon
  • Richardson Celeste
  • Singh Reshma
  • Song Huijuan
  • Wu Qilong
  • Zhang Jiquan
RU2747384C2
MEDICATION FOR TREATMENT OF LIVER CANCER 2009
  • Kinosita Jasuko
  • Sugimoto Masamiti
  • Isiguro Takakhiro
RU2523897C2
ANTIBODY TO CLDN18.2 AND ITS USE 2018
  • Du Liang
  • Zhang Hongyan
  • Ling Wen
  • Yuan Jijun
RU2797709C2
THERAPEUTIC ANTIBODIES AND THEIR APPLICATION 2016
  • Kuo Tracy Chia-Chien
  • Chaparro Riggers Javier Fernando
  • Chen Wei
  • Chen Amy Shaw-Ru
  • Pascua Edward Derrick
  • Van Blarcom Thomas John
  • Boustany Leila Marie
  • Ho Weihsien
  • Yeung Yik Andy
  • Strop Pavel
  • Rajpal Arvind
RU2722381C2
MODIFIED EXOTOXIN A PSEUDOMONADES 2014
  • Pastan Ira Kh.
  • Mazor Ronit
  • Onda Masanori
  • Li Byunkuk
  • Niderfellner Gerkhard
  • Imkhof-Yung Zabine
  • Brinkmann Ulrikh
  • Georges Gaj
RU2687143C2
ANTIBODIES TO HUMAN INTERLEUKIN-2 AND THEIR APPLICATION 2018
  • Surh, Charles D.
  • Lee, Jun-Young
RU2745451C1

RU 2 746 754 C2

Authors

Kinosita Yasuko

Kavaj Yumiko

Tsunenari Tosiaki

Isiguro Takakhiro

Endo Mika

Sano Yudzi

Dates

2021-04-20Published

2017-02-24Filed